In another meta-analysis [38] of 15 RCTs with NAFLD patients of all ages, the authors considered short-, intermediate-, and long-term follow-ups, and concluded that the group receiving vitamin E had a significant decrease in ALT and AST levels among adults. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.